Dako Overview
- Founded
- 1966

- Status
- Acquired/Merged
- Employees
- 1,300

- Latest Deal Type
- M&A
- Financing Rounds
- 2
- Investments
- 1
Dako General Information
Description
Manufacturer of reagents, antibodies, instruments and software for use in anatomic pathology laboratories. The company's immunohistochemistry products including antibodies and controls, visualization systems and ancillaries for immunohistochemistry. It also offers pharmacologist kits, molecular pathology products, Special Stains kits and flow cytometry products.
Contact Information
- 6392 Via Real
- Carpinteria, CA 93013
- United States
Dako Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Dako‘s full profile, request access.
Request a free trialDako Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialDako Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Complete Genomics | Formerly VC-backed | San Jose, CA | 000 | 00000 | 000000&0 | 00000 |
00000000 000000000 | Formerly PE-Backed | Fremont, CA | 000 | 000 | 000000000000 | 000 |
00000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
0000 00 0000 | Formerly Accelerator/Incubator backed | Houston, TX | 00 | 000000&0 | ||
00000000 0000 0000 | Formerly VC-backed | Newark, CA | 000 | 000.00 | 000000&0 | 000.00 |
Dako Patents
Dako Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20020164660-A1 | Kit for use in the diagnosis cancer and detection of epidermal growth factor receptors | Granted | 01-May-2001 | 0000000000 | 0 |
US-6727072-B2 | Kit for use in the diagnosis cancer and detection of epidermal growth factor receptors | Expired - Fee Related | 01-May-2001 | 0000000000 | 0 |
US-5804404-A | Contains an imidazole buffer, a polymer, a hydroperoxide substrate, a chromogenic organic electron donor and a reducing carbohydrate stabilizing agent | Expired - Fee Related | 22-Jan-1996 | 00000000 | 00 |
US-5289140-A | Consistent diagnostic test method using microwaves | Expired - Lifetime | 16-Aug-1991 | 000000000 | 0 |
US-4960224-A | Cassette for tissue staining | Expired - Fee Related | 24-Mar-1989 | G01N1/312 | 00 |
Dako Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Lars Holmkvist | Chief Executive Officer |
Dako Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDako Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Dako‘s full profile, request access.
Request a free trialDako Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 00000000 | 03-Sep-2008 | 0000000000 | Other Healthcare Technology Systems | 000000 00 |